Intellia Therapeutics Names David Lebwohl, M.D., Chief Medical Officer

Go back to Intellia Therapeutics Names David Lebwohl, M.D., Chief Medical Officer
(NASDAQ: NTLA) Delayed: 12.89 +0.45 (3.62%)
Previous Close $12.44    52 Week High $30.40 
Open $12.65    52 Week Low $11.86 
Day High $13.13    P/E N/A 
Day Low $12.65    EPS $0.00 
Volume 1,856,564